Published Date : 2025-Apr-16
The global bioinformatics services market is expected to reach a value of US$ 12.39 billion by 2034, at a CAGR of 14.5% over the forecast period (2025–2034), fueled by expanding genomics research, drug discovery initiatives, and increasing demand for personalized medicine.
Below is a curated list of the top players dominating this sector.
Bioinformatics services are extensively used by biotech and pharmaceutical industries for quickening drug discovery and development processes. Such tools aid in uncovering disease mechanisms, discovery of potential drug targets, and prediction of drug interactions. Integrating bioinformatics in drug development is now a crucial strategy for companies looking to lower costs and timelines associated with bringing new therapies to market. As biologics and biosimilars grow, the demand for bioinformatics solutions is likely to rise.
Cloud computing provides scalable, adaptable, and affordable platforms for data storage and analysis of big data, enabling advanced bioinformatics tools to be accessible to organizations of all sizes. This movement towards cloud services is especially beneficial for small businesses and research teams that lack the means for costly infrastructure. In addition, the ability to work together globally and exchange data in real time is also propelling the adoption of cloud-based bioinformatics solutions across industries.
The bioinformatics services market is witnessing a wave of strategic alliances and partnerships driven by the pressure to leverage abilities of the service and move into new markets. Leading bioinformatics players are joining hands with pharma, academia, and IT companies to bring together talent and meet growing demand for high-performance data analysis software. The partnerships have an agenda of integrating bioinformatics with cloud computing, designing new algorithms to analyse data, and co-creating personalized medicine solutions.
Genewiz, now part of Azenta Life Sciences, is a global leader in genomics services, offering Core Services DNA sequencing, Gene synthesis, Next-generation sequencing (NGS), Bioinformatics analysis and mRNA synthesis & CRISPR services.
The company is renowned for its custom DNA sequencing solutions and clinical-grade NGS services and provides services to over 4,000 institutional customers worldwide, including academic, pharmaceutical, biotechnology, and government organizations.?
QIAGEN is a global leader in molecular diagnostics and bioinformatics, providing sample and assay technologies for molecular testing. It serves more than 500,000 customers across the life sciences, academia, and pharmaceutical industries.
Core Bioinformatics & Services
Europe: Strong market leader with R&D and manufacturing hubs in Germany, the Netherlands, and Scandinavia.
PerkinElmer Genomics delivers next-generation sequencing (NGS), whole genome sequencing (WGS), and biochemical genetic testing services to clinical, research, and pharmaceutical institutions globally.
PerkinElmer Genomics offers: Cloud-based bioinformatics portals for clinicians, Automated interpretation software (based on ACMG guidelines), Data integrations with phenotype-genotype matching tools and AI-assisted prioritization for diagnostic variants.
In 2023, PerkinElmer’s applied and food business was separated, while the life sciences & diagnostics division rebranded as Revvity, Inc., sharpening its focus on genomics, AI-enabled diagnostics, and personalized medicine.
Illumina is the undisputed global leader in next-generation sequencing (NGS) platforms and genomics technology. The company powers the research, clinical, and pharmaceutical sectors with comprehensive end-to-end genomic solutions.
Illumina’s portfolio spans: Sequencing instruments, Reagents and consumables, Clinical and population genomics solutions and Bioinformatics software for NGS data analysis and visualization.
» DNAnexus
DNAnexus is a cloud-based bioinformatics company providing secure, scalable data management and computational analysis platforms for genomic and biomedical research. Their infrastructure is trusted by hospitals, pharmaceutical companies, and national genome programs.
Eurofins Genomics is a global provider of genomics products and services, offering everything from oligonucleotide synthesis to next-generation sequencing (NGS), Sanger sequencing, and bioinformatics solutions. The division serves academic, clinical, pharma, and agri-genomics sectors.
Thermo Fisher’s bioinformatics arm operates under its Genetic Sciences, Life Sciences Solutions, and Clinical Next-Gene Sequencing business units. It provides analytical tools, pipelines, and software platforms for genomic, proteomic, transcriptomic, and clinical diagnostics data.
Charles River is a global preclinical and early-stage contract research organization (CRO), offering services that span discovery, development, safety, and efficacy testing of new drug compounds. It increasingly integrates bioinformatics and genomics to enhance its target discovery, safety biomarkers, and translational modeling services.
Operates 160+ facilities in 20+ countries.
Seven Bridges is a bioinformatics software company that builds platforms for managing, analyzing, and visualizing genomics and multi-omics data at population scale. They are known for powering major federated research environments, enabling data sharing across borders and institutions.
Their solutions are built to handle petabyte-scale datasets and are compliant with major health and data privacy regulations, including HIPAA, FISMA, and GDPR.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
